Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors

Clinical trial NCT00908024 · TERMINATED

Trial details

NCT number: NCT00908024
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Head and Neck Cancer Neoplasm Metastasis

Start date: 2009-10-01
Primary completion: 2012-12-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.